{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:51:19Z","timestamp":1767981079300,"version":"3.49.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00415-005-0007-9","type":"journal-article","created":{"date-parts":[[2005,12,17]],"date-time":"2005-12-17T16:39:37Z","timestamp":1134837577000},"page":"1435-1447","source":"Crossref","is-referenced-by-count":47,"title":["Diagnostic investigation and multidisciplinary management in motor neuron disease"],"prefix":"10.1007","volume":"252","author":[{"given":"J. A.","family":"Rocha","sequence":"first","affiliation":[]},{"given":"C.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"F.","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"J.","family":"Fonseca","sequence":"additional","affiliation":[]},{"given":"J.","family":"Mendes Ribeiro","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"7_CR1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s004150050358","volume":"246","author":"Donaghy","year":"1999","unstructured":"Donaghy M (1999) Classification and clinical features of motor neuron diseases and motor neuropathies in adults. J Neurol 246:331\u2013333","journal-title":"J Neurol"},{"key":"7_CR2","unstructured":"Winderbank A (1994) Adult Motor neuron diseases. In: Munsat TL, Engel AG, Banker BQ (eds) Myology. McGrawHill, New York, pp 1854\u20131864"},{"key":"7_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0733-8619(01)00011-1","volume":"20","author":"David","year":"2002","unstructured":"David C (2002) Electrodiagnostic approach to the patient with suspected motor neuron disease. Neurol Clinics N Am 20:527\u2013555","journal-title":"Neurol Clinics N Am"},{"key":"7_CR4","unstructured":"Lou J-S (2004) Amyotrophic lateral sclerosis. In: Gilman S (ed) Neurobase. Arbor Publishing, La Jolla, CA"},{"key":"7_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1615\/CritRevPhysRehabilMed.v15.i1.20","volume":"15","author":"Han","year":"2003","unstructured":"Han JJ, et al. (2003) The amyotrophic lateral sclerosis center: A model of multidisciplinary management. Crit Rev Phys Med Rehabil 15:21\u201340","journal-title":"Crit Rev Phys Med Rehabil"},{"key":"7_CR6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0003-9993(99)90089-8","volume":"80","author":"Francis","year":"1999","unstructured":"Francis K, Bach JR, DeLisa JA (1999) Evaluation and rehabilitation of patients with adult motor neuron disease. Arch Phys Med Rehabil 80:951\u2013963","journal-title":"Arch Phys Med Rehabil"},{"key":"7_CR7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0733-8619(05)70330-3","volume":"15","author":"Ross","year":"1997","unstructured":"Ross MA (1997) Acquired motor neuron disorders. Neurol Clinics N Am 15:481\u2013500","journal-title":"Neurol Clinics N Am"},{"key":"7_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1520-6769(199809\/10)23:2<67::AID-NRC1>3.0.CO;2-1","volume":"23","author":"Robberecht","year":"1998","unstructured":"Robberecht W, Van Den Bosch L (1998) The pathogenesis of amyotrophic lateral sclerosis. Neurosci Res Commun 23:67\u201375","journal-title":"Neurosci Res Commun"},{"key":"7_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.apmr.2003.12.007","volume":"85","author":"Bryant","year":"2004","unstructured":"Bryant PR, et al. (2004) Stroke and neurodegenerative disorders. Arch Phys Med Rehabil 85(Suppl 1):21\u201333","journal-title":"Arch Phys Med Rehabil"},{"key":"7_CR10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/118.3.707","volume":"118","author":"Haverkamp","year":"1995","unstructured":"Haverkamp LJ, et al. (1995) Natural history of amyotrophic lateral sclerosis in a database population: validation of a scoring system and a model for survival prediction. Brain 118:707\u2013719","journal-title":"Brain"},{"key":"7_CR11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1212\/01.WNL.0000049472.47709.3B","volume":"60","author":"Aguila","year":"2003","unstructured":"Aguila MA, et al. (2003) Prognosis in amyotrophic lateral sclerosis\u2014a population based study. Neurology 60:813\u2013819","journal-title":"Neurology"},{"key":"7_CR12","first-page":"32","volume":"74","author":"Leigh","year":"2003","unstructured":"Leigh PN, et al. (2003) The management of motor neuron disease. J Neurol Neurosurg Psychiatry 74 (Suppl IV):32\u201347","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.0009-9163.2002.00001.x","volume":"63","author":"Krakauer","year":"2003","unstructured":"Krakauer MD, Willems PJ, Hofman A (2003) Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet 63:83\u2013101","journal-title":"Clin Genet"},{"key":"7_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D, et al. (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59\u201362","journal-title":"Nature"},{"key":"7_CR15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.410410212","volume":"2","author":"Cudkowicz","year":"1997","unstructured":"Cudkowicz ME, McKenna-Vasek D, Sapp PE, et al. (1997) Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 2:210\u2013221","journal-title":"Ann Neurol"},{"key":"7_CR16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ng1001-160","volume":"29","author":"Yang","year":"2001","unstructured":"Yang Y, Hentati A, Deng HX, et al. (2001) The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 29:160\u2013165","journal-title":"Nat Genet"},{"key":"7_CR17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/337945","volume":"70","author":"Hand","year":"2001","unstructured":"Hand CK, Khoris J, Salachas F, et al. (2001) A novel locus for familial ALS on chromosome 18q. Am J Hum Genet 70(1):251\u2013256","journal-title":"Am J Hum Genet"},{"key":"7_CR18","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/122.8.1539","volume":"122","author":"Rabin","year":"1999","unstructured":"Rabin BA, Griffin JW, Crain BJ, Scavina M, Chance PF,Cornblath DR (1999) Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 122:1539\u20131550","journal-title":"Brain"},{"key":"7_CR19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/421054","volume":"74","author":"Chen","year":"2004","unstructured":"Chen YZ, Benett CL, Huynh HM, et al. (2004) DNA\/RNA helicase gene mutations in a form of juvenile amyotrophic sclerosis (ALS4). Am J Hum Genet 74:1128\u20131135","journal-title":"Am J Hum Genet"},{"key":"7_CR20","first-page":"A279","volume":"A61","author":"Hentati","year":"1997","unstructured":"Hentati A, Ouahci K, Pericak-Vance MA, Ahmad A, et al. (1997) Linkage of a common locus for recessive amyotrophic lateral sclerosis. Am J Hum Genet A61:A279","journal-title":"Am J Hum Genet"},{"key":"7_CR21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/14660820310016084","volume":"4","author":"Hafezparast","year":"2003","unstructured":"Hafezparast M, Ahmad-Annuar A, Hummerich H, et al. (2003) Paradigms for identification of new genes in motor neuron degeneration. Amyotroph Lateral Scler Other Motor Neuron Disord 4:249\u2013257","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"7_CR22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s100480050052","volume":"2","author":"Hentati","year":"1998","unstructured":"Hentati A, Ouahci K, Pericak-Vance MA, et al. (1998) Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromossome 15q15-q22 markers. Neurogenetics 2(1):55\u201360","journal-title":"Neurogenetics"},{"key":"7_CR23","doi-asserted-by":"crossref","unstructured":"Abalkhail H, Mitchell J, Habgood J et al. A new familial amyotrphic lateral sclerosis locus on chromosome 16q12.1\u201316q12.2. Am J Hum Genet 73:383\u2013389","DOI":"10.1086\/377156"},{"key":"7_CR24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/377158","volume":"73","author":"Sapp","year":"2003","unstructured":"Sapp PC,Hosler BA, McKenna-Yasek D, et al. (2003) Identification of two novel loci for dominantly inherited familial Amyotrophic Lateral Sclerosis. Am J Hum Genet 73:397\u2013403","journal-title":"Am J Hum Genet"},{"key":"7_CR25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1086\/425287","volume":"75","author":"Nishimura","year":"2004","unstructured":"Nishimura Al, Mitne-Neto M, Silva MC, et al. (2004) A mutations in the vesicle trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 75:822\u2013831","journal-title":"Am J Hum Genet"},{"key":"7_CR26","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.284.13.1664","volume":"284","author":"Hosler","year":"2000","unstructured":"Hosler BA, Siddique T, Sapp PC, et al. (2000) Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 284:1664\u20131669","journal-title":"JAMA"},{"key":"7_CR27","first-page":"1159","volume":"55","author":"Wilhelmsen","year":"1994","unstructured":"Wilhelmsen KC, Lynch T, Pavlou E, Higgins M, Nygaard TG (1994) Localization of disinhibition-dementia parkinsonism amyotrophy complex to 17q21\u201322. Am J Hum Genet 55:1159\u20131165","journal-title":"Am J Hum Genet"},{"key":"7_CR28","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, et al. (1998) Association of missense and 5\u0192-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702\u2013705","journal-title":"Nature"},{"key":"7_CR29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1212\/01.WNL.0000134608.83927.B1","volume":"63","author":"Munch","year":"2004","unstructured":"Munch C, Sedlmeier R, Meyer T, Homberg V, et al. (2004) point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63:724\u2013726","journal-title":"Neurology"},{"key":"7_CR30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/bies.20092","volume":"26","author":"Storkebaum","year":"2004","unstructured":"Storkebaum E, Lambrechts D, Carmeliet P (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26(9):943\u2013954","journal-title":"Bioessays"},{"key":"7_CR31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/01677060490894450","volume":"18","author":"Terry","year":"2004","unstructured":"Terry PD, Kamel F, Umbach DM, et al. (2004) VEGF promoter haplotype and amyotrophic lateral sclerosis (ALS). J Neurogenet 18:429\u2013434","journal-title":"J Neurogenet"},{"key":"7_CR32","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/hmg\/3.10.1757","volume":"3","author":"Figlewicz","year":"1994","unstructured":"Figlewicz DA, Krizus A, Martinoli MG, et al. (1994) Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 3:1757\u20131761","journal-title":"Hum Mol Genet"},{"key":"7_CR33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/00005072-199209000-00008","volume":"51","author":"Corbo","year":"1992","unstructured":"Corbo M, Hays AP (1992) Peripherin and neurofilament protein coexist in spinal spheroids of motor neuron disease. J Neuropathol Exp Neurol 51:531\u2013537","journal-title":"J Neuropathol Exp Neurol"},{"key":"7_CR34","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s004150050532","volume":"246","author":"Jackson","year":"1999","unstructured":"Jackson M, Steers G, Leigh PN, et al. (1999) Polymorphisms in the Glutamate transporter gene EAAT2 in European ALS patients. J Neurol 246:1140\u20131144","journal-title":"J Neurol"},{"key":"7_CR35","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1523\/JNEUROSCI.16-13-04069.1996","volume":"16","author":"Carriedo","year":"1996","unstructured":"Carriedo SG, Yin HZ, Weiss JH (1996) Motor neurons are selectively vulnerable to AMPA\/kainate receptormediated injury in vitro. J Neurosci 16:4069\u20134079","journal-title":"J Neurosci"},{"key":"7_CR36","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1212\/WNL.58.7.1112","volume":"58","author":"Lacomblez","year":"2002","unstructured":"Lacomblez L, Doppler V, Beucher I, et al. (2002) ApoE: a potential marker of disease progression in ALS. Neurology 58:1112\u20131114","journal-title":"Neurology"},{"key":"7_CR37","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ana.410380318","volume":"38","author":"Mui","year":"1995","unstructured":"Mui S, Rebeck GW, McKenna-Yasek D, Hyman BT, Brown RH Jr. (1995) Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol 38:460\u2013463","journal-title":"Ann Neurol"},{"key":"7_CR38","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1212\/WNL.54.4.1003","volume":"54","author":"Giess","year":"2000","unstructured":"Giess R, Beck M, Goetz R, et al. (2000) Potential role of LIF as a modifier gene in the pathogenesis of amyotrophic lateral sclerosis. Neurology 54:1003\u20131005","journal-title":"Neurology"},{"key":"7_CR39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0022-510X(95)00129-P","volume":"132","author":"Orrell","year":"1995","unstructured":"Orrell RW, King AW, Lane RJ, de Belleroche JS (1995) Investigation of a null mutation of the CNTF gene in familial amyotrophic lateral sclerosis. J Neurol Sci 132:126\u2013128","journal-title":"J Neurol Sci"},{"key":"7_CR40","first-page":"149","volume":"3","author":"James","year":"1994","unstructured":"James CM, Daniels J, Wiles CM, Owen MJ (1994) Debrisoquine hydroxylase gene polymorphism in motor neuron disease. Neurodegeneration 3:149\u2013152","journal-title":"Neurodegeneration"},{"key":"7_CR41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00001756-199801260-00012","volume":"26","author":"Olkowski","year":"1998","unstructured":"Olkowski ZL (1998) Mutant AP endonuclease in patients with amyotrophic lateral sclerosis. Neuroreport Jan 26:9(2):239\u2013242","journal-title":"Neuroreport Jan"},{"key":"7_CR42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0361-9230(03)00179-5","volume":"61","author":"Carri","year":"2003","unstructured":"Carri MT, et al. (2003) Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull 61:365\u2013374","journal-title":"Brain Res Bull"},{"key":"7_CR43","first-page":"131","volume":"8","author":"Robert","year":"2001","unstructured":"Robert H, Phil B, Robberecht D (2001) Amyotrophic lateral sclerosis: Pathogenesis. Semin Neurol 8:131\u2013139","journal-title":"Semin Neurol"},{"key":"7_CR44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.410410212","volume":"2","author":"Cudkowicz","year":"1997","unstructured":"Cudkowicz ME, McKenna-Vasek D, Sapp PE, et al. (1997) Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 2:210\u2013221","journal-title":"Ann Neurol"},{"key":"7_CR45","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/120.10.1723","volume":"10","author":"Andersen","year":"1997","unstructured":"Andersen PM, Nilsson P, Ker\u00e4nen M-L, et al. (1997) Phenotypic heterogeneity in MND-patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 10:1723\u20131737","journal-title":"Brain"},{"key":"7_CR46","first-page":"S37","volume":"2","author":"Andersen","year":"2001","unstructured":"Andersen MP (2001) Genetics of sporadic ALS. ALS and other motor neuron disorders 2(Suppl 1):S37-S41","journal-title":"ALS and other motor neuron disorders"},{"key":"7_CR47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"Rosen","year":"1993","unstructured":"Rosen DR, Siddiique T, Petterson D, et al. (1993) Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59\u201362","journal-title":"Nature"},{"key":"7_CR48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00415-004-0322-6","volume":"251","author":"Jan","year":"2004","unstructured":"Jan HV, Van den Berg, Wokkle JH (2004) The future of motor neuron disease, the challenges is in the genes. J Neurol 251:491\u2013450","journal-title":"J Neurol"},{"key":"7_CR49","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/oxfordjournals.aje.a010183","volume":"151","author":"Nelson","year":"2000","unstructured":"Nelson LM, McGuire V, Longstreth WT, et al. (2000) Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol 151:156\u2013163","journal-title":"Am J Epidemiol"},{"key":"7_CR50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/aje\/kwh179","volume":"160","author":"Weisskopf","year":"2004","unstructured":"Weisskopf MG, McCullough ML, Calle EE, et al. (2004) Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am J Epidemiol 160:26\u201333","journal-title":"Am J Epidemiol"},{"key":"7_CR51","first-page":"196","volume":"18","author":"Louvel","year":"1997","unstructured":"Louvel E, Hugon J, Doble A (1997) Therapeutic advances in amyotrophic lateral sclerosis. TiPS 18:196\u2013203","journal-title":"TiPS"},{"key":"7_CR52","first-page":"12","volume":"1","author":"Barbeito","year":"2004","unstructured":"Barbeito LH (2004) A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Rev 1:12","journal-title":"Brain Res Rev"},{"key":"7_CR53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410380114","volume":"38","author":"Rothstein","year":"1995","unstructured":"Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT 1 in amyotrophic lateral sclerosis. Ann Neurol 38:73\u201384","journal-title":"Ann Neurol"},{"key":"7_CR54","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1468-1331.1998.550487.x","volume":"5","author":"Stuerenburg","year":"1998","unstructured":"Stuerenburg HJ, Kunze K (1998) Tissue nerve growth factor concentrations in neuromuscular diseases. Eur J Neurol 5:487\u2013490","journal-title":"Eur J Neurol"},{"key":"7_CR55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-5597(97)00018-X","volume":"104","author":"Georgesco","year":"1997","unstructured":"Georgesco M, Salerno A, Camu W (1997) Somatosensory evoked potentials by stimulation of lower limbs nerves in amyotrophic lateral sclerosis. Electroencephalograph Clin Neurophysiol 104:333\u2013342","journal-title":"Electroencephalograph Clin Neurophysiol"},{"key":"7_CR56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0926-6410(02)00110-6","volume":"14","author":"Haganasi","year":"2002","unstructured":"Haganasi HA, et al. (2002) Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsycological investigation and event related potentials. Cogn Brain Res 14:234\u2013244","journal-title":"Cogn Brain Res"},{"key":"7_CR57","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL (1998) World Federation of Neurology group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of Amyotrophic sclerosis. Philadelphia: FA Davis, pp 47\u201364"},{"key":"7_CR58","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/mus.880151009","volume":"15","author":"Cornbloth","year":"1992","unstructured":"Cornbloth DR, et al. (1992) Nerve conduction studies in amyotrophic sclerosis. Muscle Nerve 15:1111\u20131115","journal-title":"Muscle Nerve"},{"key":"7_CR59","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0022-510X(98)00193-2","volume":"160","author":"Rowland","year":"1998","unstructured":"Rowland LP (1998) Diagnosis of amyotrophic lateral scleoris. J Neurol Sci 160(Suppl 1):S6-S24","journal-title":"J Neurol Sci"},{"key":"7_CR60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mus.10317","volume":"27","author":"Olney","year":"2003","unstructured":"Olney RK, Lewis RA, Putnam TD, et al. (2003) Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27:117\u2013121","journal-title":"Muscle Nerve"},{"key":"7_CR61","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1097-4598(200010)23:10<1488::AID-MUS4>3.0.CO;2-E","volume":"23","author":"Daube","year":"2000","unstructured":"Daube JR (2000) Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders. Muscle Nerve 23:1488\u20131502","journal-title":"Muscle Nerve"},{"key":"7_CR62","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/mus.880161109","volume":"16","author":"Masseli","year":"1993","unstructured":"Masseli RA, Wollman RL, Leung C (1993) Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve 16:1193\u20131203","journal-title":"Muscle Nerve"},{"key":"7_CR63","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/mus.880141112","volume":"14","author":"Iijima","year":"1991","unstructured":"Iijima M, Arasaki K, Iwamoto H, et al. (1991) Maximal and minimal motor nerve conduction velocities in patients with motor neuron diseases. Muscle Nerve 14:1110\u20131115","journal-title":"Muscle Nerve"},{"key":"7_CR64","unstructured":"Clifford R, et al. (2002) Normal aging, dementia, and neurodegenerative disease-amyotrophic lateral sclerosis. In: Atlas SW (ed) Magnetic resonance imaging of the brain and spine. Lippincott Wand W, Philadelphia, pp 1227\u20131229"},{"key":"7_CR65","unstructured":"Osborn AG (1994) Infection, aquired metabolic,white matter, and degenerative diseases of the brain\u2014amyotrophic lateral sclerosis. In: Osborn AG (ed) Diagnostic Neuroradiology. Mosby, St Louis, pp 778\u2013779"},{"key":"7_CR66","unstructured":"Grossman RI, Yousem DM (2003) Neurodegenerative diseases and hydrocephalus-amyotrophic lateral sclerosis. In: Grossman RI, Yousem DM (eds) Neuroradiology\u2014The requisites.Mosby, USA, pp 388\u2013389"},{"key":"7_CR67","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1468-1331.1999.660629.x","volume":"6","author":"Comi","year":"1999","unstructured":"Comi G, Rovaris M, Leocani L (1999) Neuroimaging in amyotrophic lateral sclerosis. Eur J Neurol 6:629\u2013637","journal-title":"Eur J Neurol"},{"key":"7_CR68","first-page":"647","volume":"21","author":"Bowen","year":"2000","unstructured":"Bowen BC, et al. (2000) MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR 21:647\u2013648","journal-title":"AJNR"},{"key":"7_CR69","first-page":"476","volume":"24","author":"Kalra","year":"2003","unstructured":"Kalra S, et al. (2003) Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy. AJNR 24:476\u2013480","journal-title":"AJNR"},{"key":"7_CR70","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.53.5.1051","volume":"53","author":"Ellis","year":"1999","unstructured":"Ellis CM, et al. (1999) Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 53(5):1051\u20131058","journal-title":"Neurology"},{"key":"7_CR71","first-page":"1044","volume":"20","author":"Ulug","year":"1999","unstructured":"Ulug AM, et al. (1999) Clinical use of Diffusion-Tensor Imaging for diseases causing neuronal and axonal damage. AJNR 20:1044\u20131048","journal-title":"AJNR"},{"key":"7_CR72","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00234-003-1114-x","volume":"46","author":"Sundgren","year":"2004","unstructured":"Sundgren PC, et al. (2004) Diffusion tensor imaging of the brain: review of clinical applications. Neuroradiology 46:339\u2013350","journal-title":"Neuroradiology"},{"key":"7_CR73","first-page":"1541","volume":"18","author":"Kato","year":"1997","unstructured":"Kato, et al. (1997) Detection of pyramidal tract lesions in amyotrophic lateral sclerosis with magnetization-transfer measurements. AJNR 18:1541\u20131547","journal-title":"AJNR"},{"key":"7_CR74","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"Bensimon","year":"1994","unstructured":"Bensimon GL, Lacomblez L, Meininger V (1994) A control trial of riluzole in amyotrophic sclerosis. N Engl J Med 330:585\u2013591","journal-title":"N Engl J Med"},{"key":"7_CR75","first-page":"26","volume":"243","author":"Borasio","year":"1996","unstructured":"Borasio GD, et al. (1996) A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS\/IGF-I Study Group. J Neurol 243(Suppl 2):26","journal-title":"J Neurol"},{"key":"7_CR76","doi-asserted-by":"crossref","unstructured":"ALS CNTF Treatment Study (ACTS) Phase III (1996) Study Group A double-blind placebo-controlled trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 46:1244\u20131249","DOI":"10.1212\/WNL.46.5.1244"},{"key":"7_CR77","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/PL00007719","volume":"244","author":"Gian Domenico Borasio","year":"1997","unstructured":"Gian Domenico Borasio, Raymond Voltz (1997) Palliative care in amyotrophic lateral sclerosis. J Neurol 244(Suppl 4):S11\u2013S17","journal-title":"J Neurol"},{"key":"7_CR78","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1212\/WNL.59.3.428","volume":"59","author":"Ganzini","year":"2002","unstructured":"Ganzini L, Johnston S, Silveira MJ (2002) The final month in patients with ALS. Neurology 59:428\u2013431","journal-title":"Neurology"},{"key":"7_CR79","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/brain\/124.10.2000","volume":"124","author":"Lyall","year":"2001","unstructured":"Lyall RA, Donaldson N, Polkey MI, et al. (2001) Respiratory muscle strength and ventilatory failure in amyotrophic sclerosis. Brain 124(10):2000\u20132013","journal-title":"Brain"},{"key":"7_CR80","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/1531-8249(199912)46:6<887::AID-ANA11>3.0.CO;2-L","volume":"46","author":"Fitting","year":"1999","unstructured":"Fitting JW, Paillex R, Hirt L, et al. (1999) Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis. Ann Neurol 46(6):887\u2013893","journal-title":"Ann Neurol"},{"key":"7_CR81","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1164\/rccm.200403-314OC","volume":"171","author":"Morgan","year":"2005","unstructured":"Morgan RK, McNally S, Alexander M, et al. (2005) Use of sniff-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Resp Crit Care Med 171:269\u2013274","journal-title":"Am J Resp Crit Care Med"},{"key":"7_CR82","unstructured":"Miller RG, et al. (1999) \u201cPractice parameter: the care of the patient with amyotrophic lateral sclerosis- an evidence-based review\u201d, American Academy of Neurology-Guidelines for Care in ALS"},{"key":"7_CR83","unstructured":"Krivickas LS (2000) Symptom management and rehabilitation in ALS. AAEM course handout. Update on Motor Neuron Dis"},{"key":"7_CR84","first-page":"72","volume":"15","author":"Bach","year":"1995","unstructured":"Bach J (1995) respiratory muscle aids for prevention of morbidity and mortality. Scand Neurol 15:72\u201383","journal-title":"Scand Neurol"},{"key":"7_CR85","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm\/139.6.1418","volume":"139","author":"Schiffman","year":"1989","unstructured":"Schiffman PL, Belsh JM (1989) Effect of inspiratory resistance and theophylline on respiratory muscle strength in patients with amyotrophic lateral sclerosis. Am Rev Resp Dis 139:1418\u20131423","journal-title":"Am Rev Resp Dis"},{"key":"7_CR86","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-4598(200103)24:3<403::AID-MUS1013>3.0.CO;2-3","volume":"24","author":"Aboussouan","year":"2001","unstructured":"Aboussouan LS, Khan SU, Banerjee M, et al. (2001) Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve 24:403\u2013409","journal-title":"Muscle Nerve"},{"key":"7_CR87","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0003-9993(99)90089-8","volume":"80","author":"Francis","year":"1999","unstructured":"Francis K, DeLisa J (1999) Evaluation and rehabilitation of patients with adult motor neuron disease. Arch Phys Med Rehabil 80:951\u2013963","journal-title":"Arch Phys Med Rehabil"},{"key":"7_CR88","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7326\/0003-4819-127-6-199709150-00006","volume":"127","author":"Aboussouan","year":"1997","unstructured":"Aboussouan LS, Khan SU, Meeker DP, Stelmach K, Mitsumoto H (1997) Effect of non-invasive positive-pressure ventilation on survival im amyotrophic lateral sclerosis. Ann Inter Med 127:450\u2013453","journal-title":"Ann Inter Med"},{"key":"7_CR89","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000058901.75728.4E","volume":"60","author":"Stambler","year":"2003","unstructured":"Stambler N, Charantan M, Cedarbaum JM (2003) Prognostic indicators of survival in ALS. Neurology 60:1252\u20131258","journal-title":"Neurology"},{"key":"7_CR90","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","volume":"74","author":"Kasarskis","year":"2001","unstructured":"Kasarskis EJ, Berryman S, et al. (2001) Nutritional status of patients with ALS: relation to proximity of death. Am J Clin Nutr 74:328\u2013334","journal-title":"Am J Clin Nutr"},{"key":"7_CR91","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/BF00866922","volume":"242","author":"Mazzini","year":"1995","unstructured":"Mazzini L, Corra T, et al. (1995) Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. Neurology 242:695\u2013698","journal-title":"Neurology"},{"key":"7_CR92","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0022-510X(99)00230-0","volume":"169","author":"Kasaskis","year":"1999","unstructured":"Kasaskis EJ, Scarlata D, Hill R, et al. (1999) A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 169:118\u2013125","journal-title":"J Neurol Sci"},{"key":"7_CR93","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1148\/radiol.2243010909","volume":"224","author":"Thornton","year":"2002","unstructured":"Thornton FJ, et al. (2002) Amyotrophic lateral sclerosis: enteral nutrition provision: endoscopic or radiologic gastrostomy? Radiology 224:713\u2013717","journal-title":"Radiology"},{"key":"7_CR94","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-510X(01)00610-4","volume":"191","author":"Drory","year":"2001","unstructured":"Drory VE, Goltsman E, Reznik JG (2001) The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 191:133\u2013137","journal-title":"J Neurol Sci"},{"key":"7_CR95","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/136140969100500401","volume":"5","author":"Brinkmann","year":"1991","unstructured":"Brinkmann JR, Ringel SP (1991) Effectiveness of exercise in progressive neuromuscular disease. J Neurol Rehabil 5:195\u2013199","journal-title":"J Neurol Rehabil"},{"key":"7_CR96","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/pmj.78.923.513","volume":"78","author":"Talbot","year":"2002","unstructured":"Talbot K (2002) Motor neurone disease. Postgrad Med J 78:513\u2013519","journal-title":"Postgrad Med J"},{"key":"7_CR97","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0022-510X(96)00087-1","volume":"139","author":"Oliver","year":"1996","unstructured":"Oliver D (1996) The quality of care and symptom control-the effects on the terminal phase of MND\/ALSJ. Neurol Sc 139(Suppl):134\u2013136","journal-title":"Neurol Sc"},{"key":"7_CR98","unstructured":"World Health organization (1990) Cancer pain relief. Report of the WHO expert comitee. Technical report series 804. Geneva: World Health Organization"},{"key":"7_CR99","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0404.1989.tb03851.x","volume":"80","author":"Gallagher","year":"1989","unstructured":"Gallagher JP (1989) Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 80:114\u2013117","journal-title":"Acta Neurol Scand"},{"key":"7_CR100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2001-15268","volume":"21","author":"Borasio","year":"2001","unstructured":"Borasio GD, Miller RG (2001) Clinical Characteristics and Management of ALS Semin Neurol 21(2):155\u2013166","journal-title":"Semin Neurol"},{"key":"7_CR101","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1474-7766.2002.00402.x","volume":"2","author":"David Oliver","year":"2002","unstructured":"David Oliver (2002) Paliative care for motor neuron disease. Pract Neurol 2:68\u201380","journal-title":"Pract Neurol"},{"key":"7_CR102","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM198506063122303","volume":"312","author":"Schiffer","year":"1985","unstructured":"Schiffer RB, Herndon RM, Rudick RA (1985) Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med 312:1480\u20131482","journal-title":"N Engl J Med"},{"key":"7_CR103","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/PL00007719","volume":"244","author":"Borasio","year":"1997","unstructured":"Borasio GD, Voltz R (1997) Palliative care in amyotrophic lateral sclerosis. J Neurol 244(Suppl 4):S11-S17","journal-title":"J Neurol"},{"key":"7_CR104","first-page":"532","volume":"19","author":"Iannacone","year":"1996","unstructured":"Iannacone S, Strambi FL (1996) Pharmacological management of emotional lability. Clin Pharmacol 19:532\u2013535","journal-title":"Clin Pharmacol"},{"key":"7_CR105","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","volume":"63","author":"Brooks","year":"2004","unstructured":"Brooks BR, Thisted RA, Appel SH (2004) Treatment of pseudobulbar affect in ALS with dextromethorphan\/quinidine\u2014A randomized trial. Neurology 63:1364\u20131370","journal-title":"Neurology"},{"key":"7_CR106","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0306-9877(97)90103-1","volume":"48","author":"Bushara","year":"1997","unstructured":"Bushara KO (1997) Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment: botulinum A injections of the parotid glands. Med Hypotheses 48:337\u2013339","journal-title":"Med Hypotheses"},{"key":"7_CR107","first-page":"697","volume":"667","author":"Bathia","year":"1999","unstructured":"Bathia KP, Munchau A, Brown P (1999) Botulinum toxin is a useful treatment in excessive drooling in saliva. J Neurol Neurosurg Psychiatry 667:697","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7_CR108","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/mus.1208","volume":"24","author":"Benditt","year":"2001","unstructured":"Benditt JO, Smith TS, Tonelli MR (2001) Empowering the individual with ALS at the end-of-life: disease-specific advance care planning. Muscle Nerve 24:1706\u20131709","journal-title":"Muscle Nerve"},{"key":"7_CR109","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0025-6196(12)61577-8","volume":"66","author":"Silverstein","year":"1991","unstructured":"Silverstein MD, Stocking CB, Antel JP (1991) Amyotrophic lateral sclerosis and life-sustaining therapy. Mayo Clin Proc 66:906\u2013913","journal-title":"Mayo Clin Proc"},{"key":"7_CR110","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s004150170140","volume":"248","author":"Neudert","year":"2001","unstructured":"Neudert C, Oliver D, Wasner M (2001) The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 248:612\u2013616","journal-title":"J Neurol"},{"key":"7_CR111","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/bmj.304.6825.471","volume":"304","author":"O\u2019Brien","year":"1992","unstructured":"O\u2019Brien T, Kelly M, Sunders C (1992) Motor neuron disease: a hospice perspective. BMJ 304:471\u2013473","journal-title":"BMJ"},{"key":"7_CR112","unstructured":"Standards and Accreditation Comitee Medical Guidelines Task Force (1996) Medical guidelines for determining prognosis in selected non-cancer diseases. The National Hospice Organization, pp 24\u201326"},{"key":"7_CR113","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0022-510X(97)00251-7","volume":"152","author":"Krivickas","year":"1997","unstructured":"Krivickas LS, Shocley L, Mitsumoto H (1997) Homecare of patients with amyotrophic lateral sclerosis (ALS). J Neurol Sci 152(Supple 1):S82-S89","journal-title":"J Neurol Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0007-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-005-0007-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-005-0007-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:03:54Z","timestamp":1559055834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-005-0007-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":113,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["7"],"URL":"https:\/\/doi.org\/10.1007\/s00415-005-0007-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}